AAAAAA

   
Results: 1-7 |
Results: 7
DOSE-ESCALATION AND PHARMACODYNAMIC STUDY OF TOPOTECAN IN COMBINATIONWITH CYCLOPHOSPHAMIDE IN PATIENTS WITH REFRACTORY CANCER
Authors: MURREN JR ANDERSON S FEDELE J PIZZORNO G BELLIVEAU D ZELTERMAN D BURTNESS BA TOCINO I FLYNN SD BEIDLER D CHENG YC
Citation: Jr. Murren et al., DOSE-ESCALATION AND PHARMACODYNAMIC STUDY OF TOPOTECAN IN COMBINATIONWITH CYCLOPHOSPHAMIDE IN PATIENTS WITH REFRACTORY CANCER, Journal of clinical oncology, 15(1), 1997, pp. 148-157
TRIFLUOPERAZINE AS A MODULATOR OF MULTIDRUG-RESISTANCE IN REFRACTORY BREAST-CANCER
Authors: MURREN JR DURIVAGE HJ BUZAID AC REISS M FLYNN SD CARTER D HAIT WN
Citation: Jr. Murren et al., TRIFLUOPERAZINE AS A MODULATOR OF MULTIDRUG-RESISTANCE IN REFRACTORY BREAST-CANCER, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 65-70
MECHANISM OF TECHNETIUM 99M SESTAMIBI PARATHYROID IMAGING AND THE POSSIBLE ROLE OF P-GLYCOPROTEIN
Authors: MITCHELL BK CORNELIUS EA ZOGHBI S MURREN JR GHOUSSOUB R FLYNN SD KINDER BK
Citation: Bk. Mitchell et al., MECHANISM OF TECHNETIUM 99M SESTAMIBI PARATHYROID IMAGING AND THE POSSIBLE ROLE OF P-GLYCOPROTEIN, Surgery, 120(6), 1996, pp. 1039-1045
BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH BREQUINAR - RESULTS OF A PHASE-I STUDY
Authors: BUZAID AC PIZZORNO G MARSH JC RAVIKUMAR TS MURREN JR TODD M STRAIR RK POO WJ HAIT WN
Citation: Ac. Buzaid et al., BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH BREQUINAR - RESULTS OF A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 36(5), 1995, pp. 373-378
CISPLATIN, DOXORUBICIN, MITOMYCIN-C, AND 5-FLUOROURACIL FOR THE TREATMENT OF METASTATIC NONSMALL CELL LUNG-CANCER - LIMITED ACTIVITY OF AN AGGRESSIVE CHEMOTHERAPY REGIMEN
Authors: MURREN JR DURIVAGE HJ ROSENBERG AH CHEN YT DELPRETE SA MURPHY GJ BUZAID AC HAIT WN
Citation: Jr. Murren et al., CISPLATIN, DOXORUBICIN, MITOMYCIN-C, AND 5-FLUOROURACIL FOR THE TREATMENT OF METASTATIC NONSMALL CELL LUNG-CANCER - LIMITED ACTIVITY OF AN AGGRESSIVE CHEMOTHERAPY REGIMEN, American journal of clinical oncology, 17(3), 1994, pp. 239-241
A PHASE-II TRIAL OF MITOMYCIN-C, 5-FLUOROURACIL AND RADIATION-THERAPYIN THE TREATMENT OF UNRESECTABLE NONSMALL CELL LUNG-CANCER
Authors: MURREN JR GANPULE S PAPAC R SON YH PESCHEL RE DURIVAGE H BUZAID AC LAMB L MAKUCH R HAIT WN
Citation: Jr. Murren et al., A PHASE-II TRIAL OF MITOMYCIN-C, 5-FLUOROURACIL AND RADIATION-THERAPYIN THE TREATMENT OF UNRESECTABLE NONSMALL CELL LUNG-CANCER, Oncology research, 5(2), 1993, pp. 53-57
SENSITIVITY OF K562 HUMAN CHRONIC MYELOGENOUS LEUKEMIA BLAST CELLS TRANSFECTED WITH A HUMAN MULTIDRUG-RESISTANCE CDNA TO CYTOTOXIC DRUGS AND DIFFERENTIATING AGENTS
Authors: HAIT WN CHOUDHURY S SRIMATKANDADA S MURREN JR
Citation: Wn. Hait et al., SENSITIVITY OF K562 HUMAN CHRONIC MYELOGENOUS LEUKEMIA BLAST CELLS TRANSFECTED WITH A HUMAN MULTIDRUG-RESISTANCE CDNA TO CYTOTOXIC DRUGS AND DIFFERENTIATING AGENTS, The Journal of clinical investigation, 91(5), 1993, pp. 2207-2215
Risultati: 1-7 |